ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 251 filers reported holding ACADIA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $124,862,422 | -13.0% | 5,991,479 | 0.0% | 4.21% | +19.8% |
| Q2 2023 | $143,495,922 | +27.3% | 5,991,479 | 0.0% | 3.52% | -3.2% |
| Q1 2023 | $112,759,635 | +18.2% | 5,991,479 | 0.0% | 3.63% | +25.1% |
| Q4 2022 | $95,384,346 | -2.7% | 5,991,479 | 0.0% | 2.90% | +0.3% |
| Q3 2022 | $98,021,000 | +16.1% | 5,991,479 | 0.0% | 2.89% | -0.7% |
| Q2 2022 | $84,420,000 | -41.8% | 5,991,479 | 0.0% | 2.91% | -35.8% |
| Q1 2022 | $145,114,000 | +103.1% | 5,991,479 | +95.8% | 4.54% | +99.4% |
| Q4 2021 | $71,434,000 | +988.4% | 3,060,593 | +2160.2% | 2.28% | +369.3% |
| Q2 2020 | $6,563,000 | -52.0% | 135,413 | -58.2% | 0.48% | -66.1% |
| Q1 2020 | $13,684,000 | -36.0% | 323,889 | -35.2% | 1.43% | -25.8% |
| Q4 2019 | $21,390,000 | – | 500,000 | – | 1.93% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 563,200 | $16,243,000 | 9.48% |
| Avoro Capital Advisors LLC | 1,486,460 | $42,870,000 | 8.66% |
| Baker Brothers Advisors | 25,819,768 | $744,642,000 | 7.30% |
| SECTORAL ASSET MANAGEMENT INC | 1,176,543 | $33,932,000 | 3.76% |
| HARVEY CAPITAL MANAGEMENT INC | 251,825 | $7,262,000 | 3.38% |
| ACUTA CAPITAL PARTNERS, LLC | 300,000 | $8,652,000 | 3.22% |
| Palo Alto Investors LP | 1,532,030 | $44,184,000 | 2.52% |
| Ghost Tree Capital, LLC | 350,000 | $10,094,000 | 2.43% |
| EMORY UNIVERSITY | 76,121 | $2,195,000 | 2.16% |
| WEATHERBIE CAPITAL, LLC | 576,784 | $16,634,000 | 2.09% |